載入...
Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?
Reducing the incidence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) is the key ultimate goal set in essentially all treatment guidelines. There has been solid evidence supporting the relationship between serum hepatitis B virus (HBV) DNA level and risk of HCC. Antivir...
Na minha lista:
| 發表在: | J Gastroenterol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Singapore
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7567686/ https://ncbi.nlm.nih.gov/pubmed/32974760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-020-01726-3 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|